DELMAR PHARMACEUTICALS, INC. FORM SC 13G

Company

TuHURA Biosciences, Inc./NV

Filed

February 4, 2013

Accession Number

0001013762-13-000164

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →